PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4800
-0.0100 (-2.04%)
At close: May 12, 2026
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 85.3 million as of May 12, 2026. Its market cap has increased by 51.50% in one year.
Market Cap
85.30M
Enterprise Value
64.31M
Revenue
20.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.48
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 85.30M, an increase of 3,454.17%. That is a compound annual growth rate of 168.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 85.30M | 12.31% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 4.21B |
| Extendicare | 3.16B |
| Green Thumb Industries | 2.48B |
| Sienna Senior Living | 2.43B |
| Charlotte's Web Holdings | 99.55M |
| NetraMark Holdings | 97.28M |
| ME Therapeutics Holdings | 88.65M |
| Cannabix Technologies | 87.22M |